Clinical trialPhase 1Unknown
Intraoperative Radiation Therapy for Resectable Pancreas Cancer
Phase I Study of Low Kilovoltage Intraoperative Radiation for Patients With Resectable Pancreatic Adenocarcinoma
- Outcome
- Outcome unknown
- Phase
- Phase 1
- Status
- Unknown
- Study type
- Interventional
- Start
- January 2015
- Expected end
- January 2023
- Enrollment
- 12 participants
- Sites
- 1
- Primary outcomes
- Maximum Tolerated Dose
- Sponsor
- Other
- Results posted
- No
- Last update
- 4 June 2020
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Papers 4
- BackgroundPancreatic cancer: advances in treatment. DOI 10.3748/wjg.v20.i28.9354↗
- BackgroundMicroscopic margins and patterns of treatment failure in resected pancreatic adenocarcinoma. DOI 10.1001/archsurg.2012.1126↗
- BackgroundFOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. DOI 10.1056/nejmoa1011923↗
- BackgroundPancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. DOI 10.1001/archsurg.1985.01390320023003↗